WELL Health Technologies' sales grew 12% from last year and beat expectations for profit, keeping a 'Buy' rating.

Nov 12, 2026, 5:36 PM ETResultsRead the original at cantechletter.com

Good for WELL

WELL reported sales up 12% and adjusted EBITDA, a profit measure, above estimates, and kept its 2026 profit forecast. A possible U.S. asset sale could add value, but no sale is confirmed.

WELL · WELL Health Technologies

AI read · Good for WELL

The AI's read

The sales growth and profit measure beating estimates point to stronger business activity and profit generation. WELL kept its 2026 adjusted EBITDA forecast at $185 million to $195 million and set its sales outlook near $1.58 billion. A possible U.S. asset sale could add value, but no sale is confirmed.

Get alerts for WELL

Follow WELL Health Technologies (WELL) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for WELL

Free on the App Store and Google Play, or on the web.